TAP funded Tier study for relapsed and refractory CNS lymphoma patients
Re-treatment of patients refractory to daratumumab
Heinz Ludwig et al.
Immunotherapy clinical trial participation in R/R AML
The importance of individually customized treatment for CLL patients
The challenges of transplantation for patients with multiple myeloma (MM)